Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05430841
What this trial is testing

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT

Who this might be right for
Gastric CancerPancreatic CancerLiver Cancer
The First Affiliated Hospital of Xiamen University 120
Not applicableWithdrawnNCT01031056
What this trial is testing

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

Who this might be right for
Gastrointestinal NeoplasmsGynecologic CancersGynecologic Cancers Cervical Cancer+11 more
Stanford University
Early research (Phase 1)Ended earlyNCT03286062
What this trial is testing

VM110 in Detection of Microscopic Tumors: A Phase I Study

Who this might be right for
Ovarian CancerPancreatic Cancer
Fox Chase Cancer Center 1
Not applicableActive Not RecruitingNCT03631173
What this trial is testing

Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy

Who this might be right for
Pancreatic CancerPancreatic NeoplasmsBiliary Tract Cancer+2 more
Oslo University Hospital 201
Early research (Phase 1)Study completedNCT06129422
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Nihon Medi-Physics Co., Ltd. 10
Early research (Phase 1)Study completedNCT02154646
What this trial is testing

LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body

Who this might be right for
Pancreatic Neoplasms
Eli Lilly and Company 6
Not applicableUnknownNCT05313854
What this trial is testing

Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data

Who this might be right for
Pancreatic Cancer
RenJi Hospital 1,000
Not applicableNot Yet RecruitingNCT06960122
What this trial is testing

Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy

Who this might be right for
Pancreatic Cancer, ResectedDiarrhea
Second Affiliated Hospital, Zhejiang University, School of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Not applicableWithdrawnNCT05188573
What this trial is testing

EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients

Who this might be right for
Pancreatic Cancer
ClearNote Health
Testing effectiveness (Phase 2)Study completedNCT00588640
What this trial is testing

Study of D-Methadone in Patients With Chronic Pain

Who this might be right for
PainBladder CancerBreast Cancer+9 more
Memorial Sloan Kettering Cancer Center 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Early research (Phase 1)Study completedNCT01924260
What this trial is testing

Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+3 more
Edward Kim 26
Testing effectiveness (Phase 2)Study completedNCT03727880
What this trial is testing

Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Lei Zheng 28
Testing effectiveness (Phase 2)Study completedNCT00411762
What this trial is testing

A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Yale University 25
Testing effectiveness (Phase 2)Study completedNCT02420691
What this trial is testing

Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin

Who this might be right for
Advanced Digestive System Neuroendocrine NeoplasmDuodenal Neuroendocrine Tumor G1Functional Pancreatic Neuroendocrine Tumor+5 more
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)UnknownNCT04371224
What this trial is testing

NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Seoul National University Hospital 200
Not applicableStudy completedNCT00826982
What this trial is testing

Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Mayo Clinic 90
Testing effectiveness (Phase 2)Study completedNCT01395017
What this trial is testing

Dasatinib Added to Gemcitabine for Subjects With Locally-advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Otsuka Pharmaceutical Development & Commercialization, Inc. 202
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07477418
What this trial is testing

PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Borderline Resectable Pancreatic CancerPancreatic Neoplasms
University of Vermont 10
Next Page